UNCY News
Law Offices of Howard G. Smith Encourages Unicycive Therapeutics, Inc. (UNCY) Shareholders To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) common stock between December 29, 2025 and June 29, 2026, inclusive (the Class Period). Unicycive...
Business Wire
Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Securities Class Action
Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ: UNCY) securities between December 29, 2025 and June 29, 2026. Unicycive is a clinical-stage...
Business Wire
UNCY CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Unicycive Therapeutics, Inc. Investors
Glancy Prongay Wolke & Rotter LLP (GPWR), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Patel v. Unicycive Therapeutics, Inc. et al., Case No. 25-cv-09559, on behalf of persons and entities that purchased or...
Business Wire
UNCY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Unicycive Therapeutics, Inc.
The law firm of Kirby McInerney LLP continues its investigation on behalf of Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ:UNCY) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws and other unlawful business...
Business Wire
Securities Fraud Investigation Into Unicycive Therapeutics, Inc. (UNCY) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) investors concerning the Companys possible violations of the federal...
Business Wire
Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) investors concerning the Companys possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN UNICYCIVE THERAPEUTICS, INC...
Business Wire
Securities Fraud Investigation Into Unicycive Therapeutics, Inc. (UNCY) Announced Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) on behalf of investors concerning the Companys possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON UNICYCIVE THERAPEUTICS, INC...
Business Wire
UNICYCIVE THERAPEUTICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
The law firm of Kirby McInerney LLP is investigating potential claims against Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ:UNCY). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other...
Business Wire
Why Is Unicycive Therapeutics Stock Falling Tuesday?
Unicycive Therapeutics ($UNCY) stock crashes over 46% as FDA rejects kidney disease drug NDA again over third-party manufacturing issues.read more...
Benzinga